UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001679
Receipt number R000002027
Scientific Title Effect of rabeprazole and sucralfate on low-dose aspirin-related gastroduodenal mucosal injury
Date of disclosure of the study information 2009/02/02
Last modified on 2014/08/03 08:59:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of rabeprazole and sucralfate on low-dose aspirin-related gastroduodenal mucosal injury

Acronym

Effect of rabeprazole and sucralfate on low-dose aspirin-related gastroduodenal mucosal injury

Scientific Title

Effect of rabeprazole and sucralfate on low-dose aspirin-related gastroduodenal mucosal injury

Scientific Title:Acronym

Effect of rabeprazole and sucralfate on low-dose aspirin-related gastroduodenal mucosal injury

Region

Japan


Condition

Condition

Patients having taken low-dose aspirin

Classification by specialty

Gastroenterology Cardiology Endocrinology and Metabolism
Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the improvement of gastroduodenal mucosal injury in patients having taken low-dose aspirin

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of endoscopic finding before and 4 weeks after initiating rabeprazole or sucralfate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

rabeprazole 10mg/day, 4 weeks

Interventions/Control_2

sucralfate 3g/day, 4 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who have taken low-dose aspirin regularly

Key exclusion criteria

1.below 20 years of age
2.contraindication against rabeprazole and sucralfate
3.malignancy
4.pregnancy

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasushi Kuyama

Organization

Teikyo University School of Medicine

Division name

Internal Medicine

Zip code


Address

2-11-1 Kaga Itabashi-ku Tokyo

TEL

03-3964-1211

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Teikyo University School of Medicine

Division name

Internal Medicine

Zip code


Address


TEL


Homepage URL


Email

ymmt@med.teikyo-u.ac.jp


Sponsor or person

Institute

Department of Internal Medicine, Teikyo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Teikyo University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2008 Year 11 Month 26 Day

Date of IRB


Anticipated trial start date

2009 Year 02 Month 01 Day

Last follow-up date

2010 Year 09 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 02 Month 01 Day

Last modified on

2014 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002027


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name